The Commission cites challenges and delays encountered in the process.
24
Jan 2024
An EU-wide enforcement project found about 60 active substances in biocidal products that are banned.
Manufacturers and suppliers can continue to place these products on the market until their new expiration dates.
Authorised uses include cell extraction, chromatographic purification and solvent exchange and more.
Stakeholders have an opportunity to inform the new requirements for these substances.
The substance exhibits endocrine-disrupting properties with potentially adverse effects on humans.
The approval comes with specific conditions on use to protect operators, workers and bystanders.
The Commission's approval comes with specific provisions on use to ensure environmental and worker safety.
Chromium trioxide is suspected of causing cancer but the Commission decides that the benefits of these users far outweigh the risks.
